Citius Oncology Inc (TENKU) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Citius Oncology Inc  (NASDAQ: TENKU)


Citius Oncology Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Citius Oncology Inc's ROI in the third quarter of 2026?
Citius Oncology Inc recorded a cumulative net loss of $-46 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -87.02%.

Within the Healthcare sector 590 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3343 to 4059.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter		 (Mar 31 2025)
II. Quarter
Y / Y Investment Change TTM -5.77 % -37.39 % -44.83 % -40.89 % -32.07 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 79 42 51 39 42
Return On Investment (TTM) -87.02 % -102.93 % -267.72 % -246.98 % -213.55 %
TENKU's Overall Ranking # 4059 # 3343 # 0 # 3394 # 3078
Seq. Investment Change TTM 21.43 % -3.33 % -7.58 % -13.15 % -19.31 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -46 -45 -120 -120 -120

TENKU Company Profile >> Back to TENKU Roi Comparisons >> See Annual TENKU Return On Investment



Return On Investment TENKU's Ranking
Within: No.
Industry # 264
Sector # 591
Overall # 4059

Return On Investment Statistics
High Average Low
3.6 %
-101.63 %
-267.72 %
(Mar 31 2024)   (Sep 30 2025)







Financial Statements
Citius Oncology Inc's III. Quarter Investments $ 79 Millions TENKU's Balance sheet
Citius Oncology Inc's III. Quarter Income $ -9 Millions Quarterly TENKU's Income Statement
TENKU's Income by Division See TENKU's Income by Division


TENKU Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022
Total Investments in Millions 65 47 71 68 0
Y / Y Investment Growth 38.62 % -33.29 % 3.55 % - -
Net Income in Millions -6 -7 2 0 0
Y / Y Net Income Growth - - 535.3 % - -
Annual Return On Investment -8.48 % -14.14 % 3.43 % 0.56 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TENKU's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TENKU's Competitors
Subscribers only: Roi for Citius Oncology Inc's Suppliers
Subscribers only: Return On Investment for TENKU's Customers

Other Ratios
TENKU's Roa TENKU's Inventory Turnover Ratio TENKU's Growth Rates TENKU's Dividend Statistics
TENKU's Profitability Ratios TENKU's Asset Turnover Ratio TENKU's Dividend Growth
TENKU's Roe TENKU's Valuation Ratios TENKU's Financial Strength Ratios TENKU's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:42:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.